glp-1 colorectal cancer mortality study november 2025 Weight-Loss Meds Linked to Improved Colon Survival Mapping the effectiveness and risks

Read the full study here #ChronicPainRelief #BackPainSupport #PainManagement #ResearchBacked #NaturalPainRelief #HolisticHealth #WellnessScience #AlternativeMedicine #ChronicBackPain #PainCare #SleepBetterLiveBetter #MobilityMatters #EvidenceBasedRelief #HolisticWellness #BackPainAwareness #ChronicPainCommunity #PainReliefJourney #ScienceInWellness #QualityOfLifeMatters #WellnessInnovation To view or add a comment, sign in Were now seeing incretin-based therapies originally developed for diabetes and obesity being studied directly in obstructive sleep apnoea (OSA)

Ph n tin mn kinh, mn kinh mun n nh ni tit v ci thin da

Eli Lilly has stated it plans to do so this year for orforglipron as an obesity treatment, and in 2026 for treating patients with diabetes

Survival of many chronic illnesses in childhood are leading to a growing incidence of secondary osteoporosis (6)